<DOC>
	<DOCNO>NCT02177500</DOCNO>
	<brief_summary>An eight week study compare effect fix dose combination Telmisartan 40 mg plus hydrochlorothiazide ( HCTZ ) 12.5 mg Telmisartan 40 mg alone diastolic systolic blood pressure patient fail respond adequately telmisartan monotherapy .</brief_summary>
	<brief_title>Telmisartan Plus Hydrochlorothiazide Subjects With Mild-to-moderate Hypertension Who Failed Respond Telmisartan Monotherapy</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Telmisartan , hydrochlorothiazide drug combination</mesh_term>
	<criteria>History mildtomoderate hypertension Patients fail respond adequately telmisartan monotherapy Participants 18 80 year age Willingness ability provide write informed consent Patients take three antihypertensive medication screen visit Premenopausal woman Who surgically sterile Who NOT practice acceptable mean birth control NOT plan continue use acceptable method throughout study . Acceptable method birth control include intrauterine device ( IUD ) , oral , implantable injectable contraceptive Any woman : Who positive serum pregnancy test screening ( Visit 1 ) baseline ( Visit 3 ) Who nurse Hepatic and/or renal dysfunction define follow laboratory parameter SGPT ( serum glutamate pyruvate transaminase ) SGOT ( serum glutamate oxaloacetate transaminase ) great two time upper limit normal Serum creatinine &gt; 2.3 mg/dL Clinically relevant sodium depletion , hyperkalemia , hypokalemia baseline Known suspect secondary hypertension Bilateral renal artery stenosis ; renal artery stenosis solitary kidney ; postrenal transplant patient , presence one functioning kidney Congestive heart failure ( CHF ) ( NYHA ( New York Heart Association ) functional class CHF IIIIV ) Unstable angina within past three month Stroke within past six month Myocardial infarction cardiac surgery within past three month PTCA ( percutaneous transluminal coronary angioplasty ) within past three month History symptom characteristic angioedema treatment ACE inhibitor , angiotension II antagonist , thiazide diuretic , βblockers calcium channel blocker Sustained ventricular tachycardia , atrial fibrillation , atrial flutter clinically relevant cardiac arrhythmia determine investigator Hypertrophic obstructive cardiomyopathy , aortic stenosis , hemodynamically relevant stenosis aortic mitral valve Administration digoxin digitalistype drug Patients Type I Type II diabetes mellitus whose diabetes stable control least past three month define HbA1C ≥ 10 % Known drug alcohol dependency within past one year period Concomitant administration medication know affect blood pressure , except medication allow protocol Patients receive investigational therapy within one month signing informed consent form . Patients participate previous telmisartan ( except fix dose combination 502.261 study enrol 502.321 openlabel extension study ) study may participate study provide least one month discontinue previous study sign consent present study Known hypersensitivity component formulation Any clinical condition , opinion investigator , would allow safe completion protocol safe administration trial medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>